Structural and mechanistic insights into the oxy form of tyrosinase from molecular dynamics simulations.
The first, long time scale (16-ns) ligand field molecular dynamics (LFMD) simulations of the oxy form of tyrosinase are reported. The calculations use our existing type 3 copper force field for the peroxido-bridged [Cu(2)O(2)](2+) unit which is here translated from MMFF into the AMBER format together with a new charge scheme. The protein secondary and tertiary structures are not significantly altered by removing the 'caddie' protein, ORF378, which must be bound to tyrosinase before crystals will grow. A comprehensive principal component analysis of the Cartesian coordinates from the final 8 ns shows that the protein backbone is relatively rigid. However, the significant butterfly fold of the [Cu(2)O(2)](2+) moiety observed in the X-ray structure, presumably due to the caddie protein tyrosine at the active site, is absent in the simulations. LFMD gives a clear and persistent distinction between equatorial and axial Cu-N distances, with the latter about 0.2 A longer and remaining syn to each other. However, the two coordination spheres display important differences. LFMD simulations of the symmetric model complex [mu-eta(2):mu(2)-O(2){Cu(Meim)(3)}(2)](2+) (Meim is 5-methyl-1H-imidazole) provide a mechanism for syn-anti interchange of axial ligands which suggests, in combination with the old experimental X-ray data, the new LFMD simulations and traditional coordination chemistry arguments, that His(54) on Cu(A) is 'insipiently axial' and that a combination of a butterfly distortion of the [Cu(2)O(2)](2+) group and a rotation of the Cu(A)(His)(3) moiety converts the vacant, initially axial, binding site on Cu(A) into a much more favourable equatorial site.
Deeth
Robert J
RJ
Inorganic Computational Chemistry Group, Department of Chemistry, University of Warwick, Coventry, UK. r.j.deeth@warwick.ac.uk
Diedrich
Christian
C
D003300:Copper / Q000737:chemistry* / Q000378:metabolism; D018360:Crystallography, X-Ray; D008024:Ligands; D008958:Models, Molecular; D056004:Molecular Dynamics Simulation; D014442:Monophenol Monooxygenase / Q000737:chemistry* / Q000378:metabolism; D009942:Organometallic Compounds / Q000737:chemistry* / Q000378:metabolism; D011487:Protein Conformation; D013302:Streptomyces / Q000201:enzymology
D008024:Ligands; D009942:Organometallic Compounds; D003300:Copper; D014442:Monophenol Monooxygenase; C030973:cupric oxide
Inorg Chem. 2007 May 28;46(11):4492-503
17461575
Angew Chem Int Ed Engl. 2000 May;39(9):1591-1595
10820445
Acc Chem Res. 2002 Mar;35(3):183-91
11900522
Angew Chem Int Ed Engl. 2006 Jul 10;45(28):4546-50
16795103
Dalton Trans. 2006 Feb 28;(8):1092-100
16474895
Angew Chem Int Ed Engl. 2004 Jan 3;43(3):334-7
14705090
J Am Chem Soc. 2005 Jan 19;127(2):567-75
15643881
J Biol Inorg Chem. 2003 May;8(5):567-576
12634912
Chem Rev. 1996 Nov 7;96(7):2563-2606
11848837
J Phys Chem B. 2006 Nov 16;110(45):22842-52
17092036
Chem Commun (Camb). 2006 Jun 28;(24):2551-3
16779474
J Mol Biol. 1993 Dec 20;234(4):1207-17
7505336
J Biol Inorg Chem. 2004 Jul;9(5):577-90
15185133
Faraday Discuss. 2003;124:289-96; discussion 343-52, 453-5
14527221
Proteins. 2005 Dec 1;61(4):704-21
16231289
Phys Rev B Condens Matter. 1986 Jun 15;33(12):8822-8824
9938299
J Am Chem Soc. 2001 May 30;123(21):4938-50
11457321
J Phys Chem A. 2006 Feb 9;110(5):1991-2004
16451035
Inorg Chem. 2000 Sep 4;39(18):4059-72
11198861
J Comput Chem. 2005 Jan 30;26(2):123-30
15584081
Phys Rev A Gen Phys. 1988 Sep 15;38(6):3098-3100
9900728
Gene. 2007 Aug 15;398(1-2):183-91
17566671
Inorg Chem. 1998 Mar 23;37(6):1202-1212
11670324
J Biol Chem. 2003 Feb 28;278(9):7381-9
12473668
J Biol Chem. 2006 Mar 31;281(13):8981-90
16436386
Acc Chem Res. 2007 Jul;40(7):592-600
17461541
J Comput Chem. 2002 May;23(7):697-705
11948587
Inorg Chem. 2008 Apr 7;47(7):2494-506
18293917